Eurocine Vaccines operates in the pharmaceutical industry with a focus on developing vaccines for the global market. The company develops vaccine candidates from early innovation and licenses them to partners for further development and commercialization. The activities are carried out in the bioscience cluster at Karolinska Institutet in Solna, Sweden.

Quotes for Eurocine Vaccines AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Hans Arwidsson

Chairperson of the Board

  • Pierre Morgon

Board

  • Emanuele Montomoli
  • Hans Arwidsson
  • Pär Thuresson

Videos

Largest Owners

Name Capital % Votes % Date
Thomas Eldered 8,33 8,33 2023-09-27
Avanza Pension 6,28 6,28 2023-09-27
Tony Chouha 3,10 3,10 2023-09-27
Nordnet Pensionsförsäkring 3,09 3,09 2023-09-27
Ghanem Georges Chouha 2,84 2,84 2023-09-27
Bertil Furberg 2,09 2,09 2023-09-27
Göran Erlandsson 1,67 1,67 2023-09-27
Mats Kenneth Pettersson 1,57 1,57 2023-09-27
Ken Brian Levicki 1,37 1,37 2023-09-27
Ari Veli Juhani Korpela 1,34 1,34 2023-09-27
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2023-12-29 Årsstämma 2023